Hannover Re (FRA:HNR1) Earns “Sell” Rating from Barclays

Barclays restated their sell rating on shares of Hannover Re (FRA:HNR1) in a report issued on Wednesday morning, Borsen Zeitung reports.

Several other analysts have also recently weighed in on the company. HSBC set a €118.00 ($137.21) price target on Hannover Re and gave the stock a sell rating in a report on Monday, June 3rd. Deutsche Bank set a €122.00 ($141.86) price target on Hannover Re and gave the stock a neutral rating in a report on Friday, August 9th. DZ Bank restated a neutral rating on shares of Hannover Re in a report on Thursday, August 8th. Independent Research set a €145.00 ($168.60) price target on Hannover Re and gave the stock a neutral rating in a report on Thursday, August 8th. Finally, UBS Group set a €135.00 ($156.98) price objective on Hannover Re and gave the stock a neutral rating in a research note on Friday, August 30th. Six research analysts have rated the stock with a sell rating and eleven have given a hold rating to the stock. The company has an average rating of Hold and a consensus target price of €124.16 ($144.37).

FRA:HNR1 opened at €151.20 ($175.81) on Wednesday. The stock’s 50-day moving average is €144.77 and its 200-day moving average is €137.57. Hannover Re has a 1-year low of €94.75 ($110.17) and a 1-year high of €116.37 ($135.31).

Hannover Re Company Profile

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.

Read More: Using the New Google Finance Tool

Analyst Recommendations for Hannover Re (FRA:HNR1)

Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.